Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL1082723 (Cipargamin, Cipargamina, Cipargamine, Kae609, KAE-609, KAE609, NITD-609, NITD609) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
A2A receptor/Adenosine A2a receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL251] [GtoPdb: 19] [UniProtKB: P29274] | ||||||||
ChEMBL | Binding affinity to human recombinant adenosine 2a receptor | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
A3 receptor/Adenosine A3 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL256] [GtoPdb: 21] [UniProtKB: P0DMS8] | ||||||||
ChEMBL | Binding affinity to human recombinant adenosine 3 receptor | B | 5.08 | pIC50 | 8300 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
α1A-adrenoceptor/Alpha-1a adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL229] [GtoPdb: 22] [UniProtKB: P35348] | ||||||||
ChEMBL | Binding affinity to human recombinant alpha 1a receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
α2A-adrenoceptor/Alpha-2a adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1867] [GtoPdb: 25] [UniProtKB: P08913] | ||||||||
ChEMBL | Binding affinity to human recombinant alpha-2a receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
α2B-adrenoceptor/Alpha-2b adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1942] [GtoPdb: 26] [UniProtKB: P18089] | ||||||||
ChEMBL | Binding affinity to human recombinant alpha2b receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
α2C-adrenoceptor/Alpha-2c adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1916] [GtoPdb: 27] [UniProtKB: P18825] | ||||||||
ChEMBL | Binding affinity to human recombinant alpha2c receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
Androgen receptor/Androgen Receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1871] [GtoPdb: 628] [UniProtKB: P10275] | ||||||||
ChEMBL | Binding affinity to human recombinant androgen receptor | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
β1-adrenoceptor/Beta-1 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL213] [GtoPdb: 28] [UniProtKB: P08588] | ||||||||
ChEMBL | Binding affinity to human recombinant adrenergic beta-1 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
β2-adrenoceptor/Beta-2 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL210] [GtoPdb: 29] [UniProtKB: P07550] | ||||||||
ChEMBL | Binding affinity to human recombinant adrenergic beta2 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
β3-adrenoceptor/Beta-3 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL246] [GtoPdb: 30] [UniProtKB: P13945] | ||||||||
ChEMBL | Binding affinity to human recombinant adrenergic beta3 receptor | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
B1 receptor/Bradykinin B1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4308] [GtoPdb: 41] [UniProtKB: P46663] | ||||||||
ChEMBL | Binding affinity to human recombinant bradykinin B1 receptor | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
B2 receptor/Bradykinin B2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3157] [GtoPdb: 42] [UniProtKB: P30411] | ||||||||
ChEMBL | Binding affinity to human recombinant bradykinin B2 receptor | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
CB1 receptor/Cannabinoid CB1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL218] [GtoPdb: 56] [UniProtKB: P21554] | ||||||||
ChEMBL | Binding affinity to human recombinant cannabinoid 1 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
CCK1 receptor/Cholecystokinin A receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1901] [GtoPdb: 76] [UniProtKB: P32238] | ||||||||
ChEMBL | Binding affinity to human recombinant cholecystokinin A receptor | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
CCK2 receptor/Cholecystokinin B receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL298] [GtoPdb: 77] [UniProtKB: P32239] | ||||||||
ChEMBL | Binding affinity to human recombinant cholecystokinin B receptor | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
CRF1 receptor/Corticotropin releasing factor receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1800] [GtoPdb: 212] [UniProtKB: P34998] | ||||||||
ChEMBL | Binding affinity to human recombinant CRF1 receptor | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
CRF2 receptor/Corticotropin releasing factor receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4069] [GtoPdb: 213] [UniProtKB: Q13324] | ||||||||
ChEMBL | Binding affinity to human recombinant CRF2alpha receptor | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
COX-1 /Cyclooxygenase-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL221] [GtoPdb: 1375] [UniProtKB: P23219] | ||||||||
ChEMBL | Binding affinity to human recombinant COX1 | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
COX-2 /Cyclooxygenase-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL230] [GtoPdb: 1376] [UniProtKB: P35354] | ||||||||
ChEMBL | Binding affinity to human recombinant COX2 | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
δ receptor/Delta opioid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL236] [GtoPdb: 317] [UniProtKB: P41143] | ||||||||
ChEMBL | Binding affinity to human recombinant opiate delta receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
D1 receptor/Dopamine D1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2056] [GtoPdb: 214] [UniProtKB: P21728] | ||||||||
ChEMBL | Binding affinity to human recombinant dopamine D1 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
D2 receptor/Dopamine D2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL217] [GtoPdb: 215] [UniProtKB: P14416] | ||||||||
ChEMBL | Binding affinity to human recombinant dopamine D2 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
D3 receptor/Dopamine D3 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL234] [GtoPdb: 216] [UniProtKB: P35462] | ||||||||
ChEMBL | Binding affinity to human recombinant dopamine D3 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
D4 receptor/Dopamine D4 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL219] [GtoPdb: 217] [UniProtKB: P21917] | ||||||||
ChEMBL | Binding affinity to human recombinant dopamine D4.4 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
DAT/Dopamine transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL238] [GtoPdb: 927] [UniProtKB: Q01959] | ||||||||
ChEMBL | Binding affinity to human recombinant dopamine transporter | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ETA receptor/Endothelin receptor ET-A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL252] [GtoPdb: 219] [UniProtKB: P25101] | ||||||||
ChEMBL | Binding affinity to human recombinant endothelin A receptor | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ETB receptor/Endothelin receptor ET-B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1785] [GtoPdb: 220] [UniProtKB: P24530] | ||||||||
ChEMBL | Binding affinity to human recombinant endothelin B receptor | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
Estrogen receptor-α/Estrogen receptor alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL206] [GtoPdb: 620] [UniProtKB: P03372] | ||||||||
ChEMBL | Binding affinity to human recombinant ERalpha | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
Estrogen receptor-β/Estrogen receptor beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL242] [GtoPdb: 621] [UniProtKB: Q92731] | ||||||||
ChEMBL | Binding affinity to human recombinant ERbeta | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
GABAA receptor α1 subunit/GABAA receptor β1 subunit/GABAA receptor β3 subunit/GABAA receptor α5 subunit/GABAA receptor α3 subunit/GABAA receptor α2 subunit/GABAA receptor β2 subunit/GABAA receptor α4 subunit/GABAA receptor α6 subunit/GABA-A receptor; agonist GABA site in Human (target type: PROTEIN COMPLEX GROUP) [ChEMBL: CHEMBL2109244] [GtoPdb: 404, 410, 412, 408, 406, 405, 411, 407, 409] [UniProtKB: P14867, P18505, P28472, P31644, P34903, P47869, P47870, P48169, Q16445] | ||||||||
ChEMBL | Binding affinity to human recombinant GABAA receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
GIP receptor/Gastric inhibitory polypeptide receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5001] [GtoPdb: 248] [UniProtKB: P43219] | ||||||||
ChEMBL | Binding affinity to rat Gip receptor | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ghrelin receptor/Ghrelin receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4616] [GtoPdb: 246] [UniProtKB: Q92847] | ||||||||
ChEMBL | Binding affinity to human recombinant Ghrelin receptor | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
glucagon receptor/Glucagon receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1985] [GtoPdb: 251] [UniProtKB: P47871] | ||||||||
ChEMBL | Binding affinity to human recombinant glucagon receptor | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
Glucocorticoid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2034] [GtoPdb: 625] [UniProtKB: P04150] | ||||||||
ChEMBL | Binding affinity to human recombinant glucocorticoid receptor | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
GluN2D/GluN3B/GluN1/GluN2A/GluN2B/GluN2C/GluN3A/Glutamate [NMDA] receptor in Human (target type: PROTEIN COMPLEX GROUP) [ChEMBL: CHEMBL2094124] [GtoPdb: 459, 461, 455, 456, 457, 458, 460] [UniProtKB: O15399, O60391, Q05586, Q12879, Q13224, Q14957, Q8TCU5] | ||||||||
ChEMBL | Binding affinity to human recombinant NMDA receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
ChEMBL | Inhibition of human ERG | B | 4.52 | pIC50 | 30440 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Inhibition of human ERG by patch clamp method | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Inhibition of human ERG by binding assay | B | 4.52 | pIC50 | >=30000 | nM | IC50 | J Med Chem (2019) 62: 10526-10562 [PMID:31385706] |
ChEMBL | Inhibition of human ERG by patch clamp method | B | 4.52 | pIC50 | >=30000 | nM | IC50 | J Med Chem (2019) 62: 10526-10562 [PMID:31385706] |
H1 receptor/Histamine H1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL231] [GtoPdb: 262] [UniProtKB: P35367] | ||||||||
ChEMBL | Binding affinity to human recombinant histamine H1 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
H2 receptor/Histamine H2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1941] [GtoPdb: 263] [UniProtKB: P25021] | ||||||||
ChEMBL | Binding affinity to human recombinant histamine H2 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
H3 receptor/Histamine H3 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL264] [GtoPdb: 264] [UniProtKB: Q9Y5N1] | ||||||||
ChEMBL | Binding affinity to human recombinant histamine H3 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
HCA2 receptor/Hydroxycarboxylic acid receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3785] [GtoPdb: 312] [UniProtKB: Q8TDS4] | ||||||||
ChEMBL | Binding affinity to human recombinant niacin receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
κ receptor/Kappa opioid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL237] [GtoPdb: 318] [UniProtKB: P41145] | ||||||||
ChEMBL | Binding affinity to human recombinant opiate kappa receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
MC3 receptor/Melanocortin receptor 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4644] [GtoPdb: 284] [UniProtKB: P41968] | ||||||||
ChEMBL | Binding affinity to human recombinant melanocortin MC3 receptor | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
MC4 receptor/Melanocortin receptor 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL259] [GtoPdb: 285] [UniProtKB: P32245] | ||||||||
ChEMBL | Binding affinity to human recombinant melanocortin MC4 receptor | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
Monoamine oxidase A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1951] [GtoPdb: 2489] [UniProtKB: P21397] | ||||||||
ChEMBL | Binding affinity to human recombinant MAOM | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
motilin receptor/Motilin receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2203] [GtoPdb: 297] [UniProtKB: O43193] | ||||||||
ChEMBL | Binding affinity to human recombinant motilin receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
μ receptor/Mu opioid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL233] [GtoPdb: 319] [UniProtKB: P35372] | ||||||||
ChEMBL | Binding affinity to human recombinant opiate mu receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
M1 receptor/Muscarinic acetylcholine receptor M1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL216] [GtoPdb: 13] [UniProtKB: P11229] | ||||||||
ChEMBL | Binding affinity to human recombinant muscarinic M1 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
M2 receptor/Muscarinic acetylcholine receptor M2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL211] [GtoPdb: 14] [UniProtKB: P08172] | ||||||||
ChEMBL | Binding affinity to human recombinant muscarinic M2 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
M3 receptor/Muscarinic acetylcholine receptor M3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL245] [GtoPdb: 15] [UniProtKB: P20309] | ||||||||
ChEMBL | Binding affinity to human recombinant muscarinic M3 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
NK1 receptor/Neurokinin 1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL249] [GtoPdb: 360] [UniProtKB: P25103] | ||||||||
ChEMBL | Binding affinity to human recombinant neurokinin NK1 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
Y1 receptor/Neuropeptide Y receptor type 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4777] [GtoPdb: 305] [UniProtKB: P25929] | ||||||||
ChEMBL | Binding affinity to human recombinant neuropeptide Y1 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
Y2 receptor/Neuropeptide Y receptor type 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4018] [GtoPdb: 306] [UniProtKB: P49146] | ||||||||
ChEMBL | Binding affinity to human recombinant neuropeptide Y2 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
NTS1 receptor/Neurotensin receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4123] [GtoPdb: 309] [UniProtKB: P30989] | ||||||||
ChEMBL | Binding affinity to human recombinant neurotensin NT1 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
NET/Norepinephrine transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL222] [GtoPdb: 926] [UniProtKB: P23975] | ||||||||
ChEMBL | Binding affinity to human recombinant norepinephrine transporter | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
phosphodiesterase 4D/Phosphodiesterase 4D in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL288] [GtoPdb: 1303] [UniProtKB: Q08499] | ||||||||
ChEMBL | Binding affinity to human recombinant PDE4D | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
ChEMBL | Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone1 bearing P-type ATPase4 I398F and P990R mutations after 72 hrs by SYBR green based fluorescence assay | F | 7.96 | pIC50 | 10.9 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antiplasmodial activity against ring stage synchronized Plasmodium falciparum 3D7 infected in erythrocytes assessed as parasitemia level after 48 hrs by flow cytometry relative to control | F | 8 | pIC50 | 10 | nM | IC50 | Eur J Med Chem (2014) 78: 375-382 [PMID:24699367] |
ChEMBL | Antimalarial activity against drug-resistant Plasmodium falciparum Dd2 harboring ATP4 P990R/D124Y double mutant | F | 8.35 | pIC50 | 4.5 | nM | IC50 | J Med Chem (2018) 61: 4213-4227 [PMID:29665687] |
ChEMBL | Antimalarial activity against Plasmodium falciparum Dd2 containing attB site inserted in parasite genome and using CAM promoter driven expressing ATP4 I398F/P990R mutant after 72 hrs by SYBR green based fluorescence assay | F | 8.37 | pIC50 | 4.25 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antimalarial activity against NITD678-resistant Plasmodium falciparum Dd2 Clone3 bearing P-type ATPase4 I203M and I263V mutations after 72 hrs by SYBR green based fluorescence assay | F | 8.39 | pIC50 | 4.1 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antimalarial activity against Plasmodium falciparum Dd2 containing attB site inserted in parasite genome and using CAM promoter driven expressing ATP4 D1247Y mutant after 72 hrs by SYBR green based fluorescence assay | F | 8.41 | pIC50 | 3.9 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone2 bearing P-type ATPase4 T418N and P990R mutations after 72 hrs by SYBR green based fluorescence assay | F | 8.43 | pIC50 | 3.7 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone3 bearing P-type ATPase4 D1247Y mutations after 72 hrs by SYBR green based fluorescence assay | F | 8.49 | pIC50 | 3.2 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antimalarial activity against NITD678-resistant Plasmodium falciparum Dd2 Clone2 bearing P-type ATPase4 A184S and P990Y mutations after 72 hrs by SYBR green based fluorescence assay | F | 8.55 | pIC50 | 2.8 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antimalarial activity against NITD678-resistant Plasmodium falciparum Dd2 Clone1 bearing P-type ATPase4 G223R mutations after 72 hrs by SYBR green based fluorescence assay | F | 8.55 | pIC50 | 2.8 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antimalarial activity against Plasmodium falciparum Dd2 containing attB site inserted in parasite genome and using EF1-alpha promoter driven expressing ATP4 I398F/P990R mutant after 72 hrs by SYBR green based fluorescence assay | F | 8.72 | pIC50 | 1.89 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antimalarial activity against Plasmodium falciparum Dd2 containing attB site inserted in parasite genome and using EF1-alpha promoter driven expressing ATP4 D1247Y mutant after 72 hrs by SYBR green based fluorescence assay | F | 8.8 | pIC50 | 1.57 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antimalarial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum V1/S after 48 hrs incubation by [3H]hypoxanthine incorporation assay | F | 8.85 | pIC50 | 1.4 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum 7G8 after 48 hrs incubation by [3H]hypoxanthine incorporation assay | F | 8.92 | pIC50 | 1.2 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antimalarial activity against Plasmodium falciparum D6 after 48 hrs incubation by [3H]hypoxanthin incorporation assay | F | 9 | pIC50 | 1 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antimalarial activity against Plasmodium falciparum Dd2 containing attB site inserted in parasite genome and using EF1-alpha promoter driven expressing wild type ATP4 after 72 hrs by SYBR green based fluorescence assay | F | 9.04 | pIC50 | 0.92 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antimalarial activity against drug-sensitive Plasmodium falciparum NF54 infected in human erythrocytes after 48 hrs by [3H]hypoxanthine assay | F | 9.05 | pIC50 | 0.9 | nM | IC50 | J Med Chem (2010) 53: 5155-5164 [PMID:20568778] |
ChEMBL | Antimalarial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum W2 | F | 9.05 | pIC50 | 0.9 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antimalarial activity against chloroquine, mefloquine and pyrimethamine-resistant Plasmodium falciparum TM91C235 after 48 hrs incubation by [3H]hypoxanthine incorporation assay | F | 9.05 | pIC50 | 0.9 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antiplasmodial activity against Plasmodium falciparum assessed as [3H]-hypoxanthine incorporation after 48 hrs by liquid scintillation counting analysis | F | 9.05 | pIC50 | 0.9 | nM | IC50 | ACS Med Chem Lett (2013) 4: 989-993 [PMID:24159368] |
ChEMBL | Antimalarial activity against Plasmodium falciparum Dd2 containing attB site inserted in parasite genome and expressing parental ATP4 after 72 hrs by SYBR green based fluorescence assay | F | 9.07 | pIC50 | 0.85 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antimalarial activity against Plasmodium falciparum 3D7 after 48 hrs incubation by [3H]hypoxanthin incorporation assay | F | 9.15 | pIC50 | 0.7 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antimalarial activity against wild type Plasmodium falciparum Dd2 | F | 9.22 | pIC50 | 0.6 | nM | IC50 | J Med Chem (2018) 61: 4213-4227 [PMID:29665687] |
ChEMBL | Antimalarial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 after 48 hrs incubation by [3H]hypoxanthine incorporation assay | F | 9.22 | pIC50 | 0.6 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antimalarial activity against Plasmodium falciparum K1 | F | 9.22 | pIC50 | 0.6 | nM | IC50 | Eur J Med Chem (2021) 210: 112955-112955 [PMID:33131885] |
ChEMBL | Antiplasmodial activity against asexual blood stage Plasmodium falciparum assessed as inhibition of parasitic growth | F | 9.3 | pIC50 | 0.5 | nM | IC50 | Bioorg Med Chem (2023) 88-89: 117339-117339 [PMID:37236020] |
ChEMBL | Antimalarial activity against Plasmodium falciparum assessed as [35S]Met/Cys incorporation by SYBR green based fluorescence assay | F | 9.3 | pIC50 | 0.5 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antimalarial activity against Plasmodium falciparum NF54 after 48 hrs incubation by [3H]hypoxanthin incorporation assay | F | 9.3 | pIC50 | 0.5 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antimalarial activity against Plasmodium falciparum NF54 | F | 9.3 | pIC50 | 0.5 | nM | IC50 | Eur J Med Chem (2021) 210: 112955-112955 [PMID:33131885] |
ChEMBL | Antimalarial activity against chloroquine, mefloquine and pyrimethamine-resistant Plasmodium falciparum TM90C2A after 48 hrs incubation by [3H]hypoxanthine incorporation assay | F | 9.3 | pIC50 | 0.5 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antimalarial activity against Plasmodium falciparum NF54 infected in human erythrocytes assessed as reduction in parasitemia incubated for 48 hrs by [3H]-hypoxanthine based liquid scintillation counting analysis | F | 9.3 | pIC50 | 0.5 | nM | IC50 | Eur J Med Chem (2023) 252: 115247-115247 [PMID:36931118] |
ChEMBL | Antiplasmodial activity against sexual blood stage Plasmodium falciparum assessed as inhibition of parasitic growth | F | 9.3 | pIC50 | 0.5 | nM | IC50 | Bioorg Med Chem (2023) 88-89: 117339-117339 [PMID:37236020] |
ChEMBL | Antimalarial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green based fluorescence assay | F | 9.36 | pIC50 | 0.44 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
ChEMBL | Antiplasmodial activity against blood stage form of Plasmodium falciparum NF54 | F | 9 | pEC50 | 1 | nM | EC50 | J Med Chem (2013) 56: 7741-7749 [PMID:23927720] |
ChEMBL | Antiplasmodial activity against drug-sensitive Plasmodium falciparum 3D7 | F | 9.15 | pEC50 | 0.7 | nM | EC50 | Bioorg Med Chem Lett (2013) 23: 2829-2843 [PMID:23587422] |
ChEMBL | Antimalarial activity against Plasmodium falciparum 3D7 infected in human erythrocytes assessed as reduction in [3H]-hypoxanthine incorporation incubated for 48 hrs followed by addition of [3H]-hypoxanthine and measured after 24 hrs by liquid scintillation counting method | F | 9.3 | pEC50 | 0.5 | nM | EC50 | J Med Chem (2019) 62: 10526-10562 [PMID:31385706] |
ChEMBL | Antimalarial activity against Plasmodium falciparum K1 infected in human erythrocytes assessed as reduction in [3H]-hypoxanthine incorporation incubated for 48 hrs followed by addition of [3H]-hypoxanthine and measured after 24 hrs by liquid scintillation counting method | F | 9.3 | pEC50 | 0.5 | nM | EC50 | J Med Chem (2019) 62: 10526-10562 [PMID:31385706] |
ChEMBL | Antimalarial activity against Plasmodium falciparum W2 infected in human erythrocytes assessed as reduction in [3H]-hypoxanthine incorporation incubated for 48 hrs followed by addition of [3H]-hypoxanthine and measured after 24 hrs by liquid scintillation counting method | F | 9.3 | pEC50 | 0.5 | nM | EC50 | J Med Chem (2019) 62: 10526-10562 [PMID:31385706] |
ChEMBL | Antimalarial activity against Plasmodium falciparum 7G8 infected in human erythrocytes assessed as reduction in [3H]-hypoxanthine incorporation incubated for 48 hrs followed by addition of [3H]-hypoxanthine and measured after 24 hrs by liquid scintillation counting method | F | 9.3 | pEC50 | 0.5 | nM | EC50 | J Med Chem (2019) 62: 10526-10562 [PMID:31385706] |
ChEMBL | Antimalarial activity against Plasmodium falciparum TM90C2A infected in human erythrocytes assessed as reduction in [3H]-hypoxanthine incorporation incubated for 48 hrs followed by addition of [3H]-hypoxanthine and measured after 24 hrs by liquid scintillation counting method | F | 9.3 | pEC50 | 0.5 | nM | EC50 | J Med Chem (2019) 62: 10526-10562 [PMID:31385706] |
ChEMBL | Antimalarial activity against Plasmodium falciparum TM91C235 infected in human erythrocytes assessed as reduction in [3H]-hypoxanthine incorporation incubated for 48 hrs followed by addition of [3H]-hypoxanthine and measured after 24 hrs by liquid scintillation counting method | F | 9.3 | pEC50 | 0.5 | nM | EC50 | J Med Chem (2019) 62: 10526-10562 [PMID:31385706] |
ChEMBL | Antimalarial activity against Plasmodium falciparum D6 infected in human erythrocytes assessed as reduction in [3H]-hypoxanthine incorporation incubated for 48 hrs followed by addition of [3H]-hypoxanthine and measured after 24 hrs by liquid scintillation counting method | F | 9.3 | pEC50 | 0.5 | nM | EC50 | J Med Chem (2019) 62: 10526-10562 [PMID:31385706] |
ChEMBL | Antimalarial activity against Plasmodium falciparum V1/S infected in human erythrocytes assessed as reduction in [3H]-hypoxanthine incorporation incubated for 48 hrs followed by addition of [3H]-hypoxanthine and measured after 24 hrs by liquid scintillation counting method | F | 9.3 | pEC50 | 0.5 | nM | EC50 | J Med Chem (2019) 62: 10526-10562 [PMID:31385706] |
ChEMBL | Antimalarial activity against Plasmodium falciparum NF54 infected in human erythrocytes assessed as reduction in [3H]-hypoxanthine incorporation incubated for 48 hrs followed by addition of [3H]-hypoxanthine and measured after 24 hrs by liquid scintillation counting method | F | 9.3 | pEC50 | 0.5 | nM | EC50 | J Med Chem (2019) 62: 10526-10562 [PMID:31385706] |
5-HT1A receptor/Serotonin 1a (5-HT1a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL214] [GtoPdb: 1] [UniProtKB: P08908] | ||||||||
ChEMBL | Binding affinity to human recombinant serotonin 5-HT1A receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
5-HT2A receptor/Serotonin 2a (5-HT2a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL224] [GtoPdb: 6] [UniProtKB: P28223] | ||||||||
ChEMBL | Binding affinity to human recombinant serotonin 5-HT2A receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
5-HT2B receptor/Serotonin 2b (5-HT2b) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1833] [GtoPdb: 7] [UniProtKB: P41595] | ||||||||
ChEMBL | Binding affinity to human recombinant serotonin 5-HT2B receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
5-HT2C receptor/Serotonin 2c (5-HT2c) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL225] [GtoPdb: 8] [UniProtKB: P28335] | ||||||||
ChEMBL | Binding affinity to human recombinant serotonin 5HT2C receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
5-HT3A/Serotonin 3a (5-HT3a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1899] [GtoPdb: 373] [UniProtKB: P46098] | ||||||||
ChEMBL | Binding affinity to human recombinant serotonin 5HT3 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
SERT/Serotonin transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL228] [GtoPdb: 928] [UniProtKB: P31645] | ||||||||
ChEMBL | Binding affinity to human recombinant serotonin transporter | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
TP receptor/Thromboxane A2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2069] [GtoPdb: 346] [UniProtKB: P21731] | ||||||||
ChEMBL | Binding affinity to human recombinant thromboxane A2 receptor | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
AT1 receptor/Type-1 angiotensin II receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL227] [GtoPdb: 34] [UniProtKB: P30556] | ||||||||
ChEMBL | Binding affinity to human recombinant angiotensin2 AT1 receptor | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
V1A receptor/Vasopressin V1a receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1889] [GtoPdb: 366] [UniProtKB: P37288] | ||||||||
ChEMBL | Binding affinity to human recombinant vasopressin V1a receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
V2 receptor/Vasopressin V2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1790] [GtoPdb: 368] [UniProtKB: P30518] | ||||||||
ChEMBL | Binding affinity to human recombinant vasopressin V2 receptor | B | 4.52 | pIC50 | >30000 | nM | IC50 | Science (2010) 329: 1175-1180 [PMID:20813948] |
Plasmodium falciparum non-SERCA-type Ca2+ -transporting P-ATPase in Plasmodium falciparum TM91C235 [GtoPdb: 2971] | ||||||||
GtoPdb | Parasite growth inhibition assay | - | 9.05 | pIC50 | 0.9 | nM | IC50 | Science (2010) 329: 1175-80 [PMID:20813948] |
Plasmodium falciparum non-SERCA-type Ca2+ -transporting P-ATPase in Plasmodium falciparum K1 [GtoPdb: 2971] | ||||||||
GtoPdb | Parasite growth inhibition assay | - | 9.22 | pIC50 | 0.6 | nM | IC50 | Science (2010) 329: 1175-80 [PMID:20813948] |
Plasmodium falciparum non-SERCA-type Ca2+ -transporting P-ATPase in Plasmodium falciparum NF54 [GtoPdb: 2971] | ||||||||
GtoPdb | Parasite growth inhibition assay | - | 9.3 | pIC50 | 0.5 | nM | IC50 | Science (2010) 329: 1175-80 [PMID:20813948] |
Plasmodium falciparum non-SERCA-type Ca2+ -transporting P-ATPase in Plasmodium falciparum 3D7 [GtoPdb: 2971] [UniProtKB: A0A143ZZK9] | ||||||||
GtoPdb | Parasite growth inhibition assay | - | 9.15 | pIC50 | 0.7 | nM | IC50 | Science (2010) 329: 1175-80 [PMID:20813948] |
Plasmodium falciparum non-SERCA-type Ca2+ -transporting P-ATPase in Plasmodium falciparum 7G8 [GtoPdb: 2971] | ||||||||
GtoPdb | Parasite growth inhibition assay | - | 8.92 | pIC50 | 1.2 | nM | IC50 | Science (2010) 329: 1175-80 [PMID:20813948] |
Plasmodium falciparum non-SERCA-type Ca2+ -transporting P-ATPase in Plasmodium falciparum D6 [GtoPdb: 2971] | ||||||||
GtoPdb | Parasite growth inhibition assay | - | 9 | pIC50 | 1 | nM | IC50 | Science (2010) 329: 1175-80 [PMID:20813948] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]